BioMarin officer files Form 3 with no share holdings

BioMarin Pharmaceutical Inc. insider filing shows no holdings for a new officer.

Accepted by SEC EDGAR 01/22/2026 - 06:09 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

BioMarin Pharmaceutical Inc. insider filing shows no holdings for a new officer. VP and Chief Accounting Officer Rashmi Virendra Ramchandani filed an initial ownership report on Form 3 for BioMarin Pharmaceutical Inc. The filing states that no securities of BioMarin are beneficially owned. This means that, as of the event date shown in the filing, the reporting officer does not report owning any shares or derivative securities of the company.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the BioMarin (BMRN) Form 3 filed by Rashmi Virendra Ramchandani show?

The Form 3 for BioMarin (BMRN) filed by VP and Chief Accounting Officer Rashmi Virendra Ramchandani reports that no securities of BioMarin are beneficially owned.

Who is the reporting person on this BioMarin (BMRN) Form 3?

The reporting person is Rashmi Virendra Ramchandani, who serves as VP, Chief Accounting Officer of BioMarin Pharmaceutical Inc.

Does the BioMarin (BMRN) officer report owning any shares on this Form 3?

No. The Form 3 explicitly notes in the remarks section that no securities are beneficially owned by the reporting person.

Are there any transactions disclosed in this BioMarin (BMRN) Form 3?

No. The filing does not list any transactions in either the non-derivative or derivative securities tables; it is an initial ownership report with no holdings reported.

What is the significance of a Form 3 with no beneficial ownership for BioMarin (BMRN)?

A Form 3 with no beneficial ownership indicates that the newly reported officer currently does not report holding BioMarin securities, providing a baseline for any future ownership changes that would be reported on Forms 4 or 5.

Is this BioMarin (BMRN) Form 3 filed by one or multiple reporting persons?

The Form 3 is indicated as filed by one reporting person, covering only Rashmi Virendra Ramchandani.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ramchandani Rashmi Virendra

(Last) (First) (Middle)

C/O BIOMARIN PHARMACEUTICAL

770 LINDARO STREEET

(Street)

SAN RAFAEL CA 94901

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/20/2026

3. Issuer Name and Ticker or Trading Symbol
BIOMARIN PHARMACEUTICAL INC [ BMRN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chief Accounting Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

No securities are beneficially owned.

	/s/ Tae Sang Yoo, Attorney-in-Fact	01/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.